Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles
Work
Year: 2009
Type: article
Abstract: Celecoxib, rofecoxib, and diclofenac are clinically used cyclooxygenase-2 (COX-2) inhibitors, which have been under intense scrutiny because long-term rofecoxib (Vioxx; Merck, Whitehouse Station, NJ) ... more
Source: Molecular Pharmacology
Authors Lioubov I. Brueggemann, Alexander R Mackie, Bharath K. Mani, Leanne L. Cribbs, Kenneth L. Byron
Institution Loyola University Chicago
Cites: 39
Cited by: 84
Related to: 10
FWCI: 9.301
Citation percentile (by year/subfield): 95.76
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green